165 related articles for article (PubMed ID: 34790402)
21. Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer.
Patel DA; Xi J; Luo J; Hassan B; Thomas S; Ma CX; Campian JL
Breast Cancer Res Treat; 2019 Apr; 174(2):443-452. PubMed ID: 30604000
[TBL] [Abstract][Full Text] [Related]
22. Impact of Pre-Treatment NLR and Other Hematologic Biomarkers on the Outcomes of Early-Stage Non-Small-Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy.
Aduquaye M; Dube S; Bashir B; Chowdhury A; Ahmed N; Leylek A; Kim J; Lambert P; Bucher O; Hunter W; Sivananthan G; Koul R; Rathod S
Curr Oncol; 2022 Jan; 29(1):193-208. PubMed ID: 35049693
[TBL] [Abstract][Full Text] [Related]
23. Pretreatment Immune Parameters Predict for Overall Survival and Toxicity in Early-Stage Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
Shaverdian N; Veruttipong D; Wang J; Schaue D; Kupelian P; Lee P
Clin Lung Cancer; 2016 Jan; 17(1):39-46. PubMed ID: 26372098
[TBL] [Abstract][Full Text] [Related]
24. Use of hematologic biomarkers during chemotherapy predicts survival in ovarian cancer patients.
Brightwell R; Eng K; Lele S
Eur J Gynaecol Oncol; 2017; 38(3):378-381. PubMed ID: 29693877
[TBL] [Abstract][Full Text] [Related]
25. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio associations with heart and body dose and their effects on patient outcomes in locally advanced non-small cell lung cancer treated with definitive radiotherapy.
Xia WY; Zhu XR; Feng W; Liu J; Wang JM; Lv CX; Zhang Q; Yu W; Cai XW; Fu XL
Transl Lung Cancer Res; 2020 Oct; 9(5):1996-2007. PubMed ID: 33209619
[TBL] [Abstract][Full Text] [Related]
26. Lymphopenia Is Associated with Gross Target Volumes and Fractions in Hepatocellular Carcinoma Patients Treated with External Beam Radiation Therapy and Also Indicates Worse Overall Survival.
Zhang HG; Yang P; Jiang T; Zhang JY; Jin XJ; Hu Y; Sun J; Du SS; Zeng ZC
Can J Gastroenterol Hepatol; 2019; 2019():9691067. PubMed ID: 31781521
[TBL] [Abstract][Full Text] [Related]
27. The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma.
Huszno J; Kolosza Z; Mrochem-Kwarciak J; Rutkowski T; Skladowski K
Oncology; 2019; 97(1):7-17. PubMed ID: 31048577
[TBL] [Abstract][Full Text] [Related]
28. Elevated neutrophil-lymphocyte ratio predicts mortality following elective endovascular aneurysm repair.
King AH; Schmaier AH; Harth KC; Kumins NH; Wong VL; Zidar DA; Kashyap VS; Cho JS
J Vasc Surg; 2020 Jul; 72(1):129-137. PubMed ID: 32037083
[TBL] [Abstract][Full Text] [Related]
29. The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors.
Pike LRG; Bang A; Mahal BA; Taylor A; Krishnan M; Spektor A; Cagney DN; Aizer AA; Alexander BM; Rahma O; Balboni T; Ott PA; Hodi FS; Schoenfeld JD
Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):142-151. PubMed ID: 30227198
[TBL] [Abstract][Full Text] [Related]
30. Neutrophil to Lymphocyte Ratio as Predictor of Treatment Response in Esophageal Squamous Cell Cancer.
Barbetta A; Nobel TB; Sihag S; Hsu M; Tan KS; Bains MS; Isbell JM; Janjigian YY; Wu AJ; Bott MJ; Jones DR; Molena D
Ann Thorac Surg; 2018 Sep; 106(3):864-871. PubMed ID: 29738752
[TBL] [Abstract][Full Text] [Related]
31. Baseline Lymphopenia: A Predictor Of Poor Outcomes In HER2 positive Metastatic Breast Cancer Treated With Trastuzumab.
Che YQ; Zhang Y; Wang D; Liu HY; Shen D; Luo Y
Drug Des Devel Ther; 2019; 13():3727-3734. PubMed ID: 31754298
[TBL] [Abstract][Full Text] [Related]
32. Developing the POTOMAC Model: A Novel Prediction Model to Study the Impact of Lymphopenia Kinetics on Survival Outcomes in Head and Neck Cancer Via an Ensemble Tree-Based Machine Learning Approach.
Kut C; Midthune D; Lee E; Fair P; Cheunkarndee T; McNutt T; DeWeese T; Fakhry C; Kipnis V; Quon H
JCO Clin Cancer Inform; 2023 Sep; 7():e2300058. PubMed ID: 38096467
[TBL] [Abstract][Full Text] [Related]
33. Association between severe treatment-related lymphopenia and progression-free survival in patients with newly diagnosed squamous cell head and neck cancer.
Campian JL; Sarai G; Ye X; Marur S; Grossman SA
Head Neck; 2014 Dec; 36(12):1747-53. PubMed ID: 24174270
[TBL] [Abstract][Full Text] [Related]
34. Prognostic implication of simultaneous anemia and lymphopenia during concurrent chemoradiotherapy in cervical squamous cell carcinoma.
Cho O; Chun M; Oh YT; Noh OK; Chang SJ; Ryu HS; Lee EJ
Tumour Biol; 2017 Oct; 39(10):1010428317733144. PubMed ID: 29022484
[TBL] [Abstract][Full Text] [Related]
35. A high neutrophil-to-lymphocyte ratio as a potential marker of mortality in patients with Merkel cell carcinoma: A retrospective study.
Zaragoza J; Kervarrec T; Touzé A; Avenel-Audran M; Beneton N; Esteve E; Wierzbicka Hainaut E; Aubin F; Machet L; Samimi M
J Am Acad Dermatol; 2016 Oct; 75(4):712-721.e1. PubMed ID: 27544490
[TBL] [Abstract][Full Text] [Related]
36. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation.
Dudani S; Marginean H; Tang PA; Monzon JG; Raissouni S; Asmis TR; Goodwin RA; Gotfrit J; Cheung WY; Vickers MM
BMC Cancer; 2019 Jul; 19(1):664. PubMed ID: 31277604
[TBL] [Abstract][Full Text] [Related]
37. Systemic inflammatory dynamics during chemoradiotherapy predict response, relapse, metastasis, and survival in esophageal carcinoma.
Sherry AD; Newman NB; Anderson JL; Osmundson EC
J Surg Oncol; 2020 Feb; 121(2):303-312. PubMed ID: 31799692
[TBL] [Abstract][Full Text] [Related]
38. Pre-treatment absolute lymphocyte count predicts for improved survival in human papillomavirus (HPV)-driven oropharyngeal squamous cell carcinoma.
Kreinbrink PJ; Li J; Parajuli S; Wise-Draper TM; Choi DL; Tang AL; Takiar V
Oral Oncol; 2021 May; 116():105245. PubMed ID: 33901866
[TBL] [Abstract][Full Text] [Related]
39. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.
Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Meng YQ; Fu XY; Ma QL; Lin P
World J Gastroenterol; 2015 May; 21(18):5591-7. PubMed ID: 25987784
[TBL] [Abstract][Full Text] [Related]
40. Comparison of clinical utility between neutrophil count and neutrophil-lymphocyte ratio in patients with ovarian cancer: a single institutional experience and a literature review.
Komura N; Mabuchi S; Yokoi E; Kozasa K; Kuroda H; Sasano T; Matsumoto Y; Kimura T
Int J Clin Oncol; 2018 Feb; 23(1):104-113. PubMed ID: 28951992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
